Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morlat

Showing results (101-110 of 174) with videos related to

Pageof 18
Sort By:
Pathologie-Biologie|October 1, 1996
Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudineP Morlat, G Chene, J M Ragnaud, et al.
La Revue De Medecine Interne|June 9, 2015
[Survey of the prescriptions of proton pump inhibitors in patients admitted in an internal medicine ward: how is the compliance to the French guidelines?]L Sauvaget, L Rolland, S Dabadie, et al.
La Revue De Medecine Interne|January 1, 1993
[Primary prevention of cerebral toxoplasmosis in patients with HIV infection: results of a double-blind randomized trial, pyrimethamine versus placebo]P Morlat, G Chene, C Leport, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosineB Masquelier, I Pellegrin, A Ruffault, et al.
Clinical Immunology (Orlando, Fla.)|May 19, 2001
Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapyM Savès, P Morlat, G Chêne, et al.
Annales De Medecine Interne|January 1, 1995
[Polycythemia secondary to pelvic leiomyosarcoma. Apropos of a case]T Mayet, D Lacoste, P Morlat, et al.
Presse Medicale (Paris, France : 1983)|January 11, 2005
[Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment]T May, C Lewden, F Bonnet, et al.
HIV Medicine|July 26, 2002
Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999F Bonnet, P Morlat, G Chêne, et al.
HIV Medicine|February 2, 2017
Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trialS Gallien, V Journot, M-A Loriot, et al.
La Revue De Medecine Interne|January 1, 1994
[Epidemiological, clinical, biological and developmental aspects of leptospirosis: apropos of 30 cases in Aquitaine]J M Ragnaud, P Morlat, M Buisson, et al.
Pageof 18

Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
Pathologie-Biologie|October 1, 1996
Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudineP Morlat, G Chene, J M Ragnaud, et al.
La Revue De Medecine Interne|June 9, 2015
[Survey of the prescriptions of proton pump inhibitors in patients admitted in an internal medicine ward: how is the compliance to the French guidelines?]L Sauvaget, L Rolland, S Dabadie, et al.
La Revue De Medecine Interne|January 1, 1993
[Primary prevention of cerebral toxoplasmosis in patients with HIV infection: results of a double-blind randomized trial, pyrimethamine versus placebo]P Morlat, G Chene, C Leport, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosineB Masquelier, I Pellegrin, A Ruffault, et al.
Clinical Immunology (Orlando, Fla.)|May 19, 2001
Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapyM Savès, P Morlat, G Chêne, et al.
Annales De Medecine Interne|January 1, 1995
[Polycythemia secondary to pelvic leiomyosarcoma. Apropos of a case]T Mayet, D Lacoste, P Morlat, et al.
Presse Medicale (Paris, France : 1983)|January 11, 2005
[Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment]T May, C Lewden, F Bonnet, et al.
HIV Medicine|July 26, 2002
Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999F Bonnet, P Morlat, G Chêne, et al.
HIV Medicine|February 2, 2017
Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trialS Gallien, V Journot, M-A Loriot, et al.
La Revue De Medecine Interne|January 1, 1994
[Epidemiological, clinical, biological and developmental aspects of leptospirosis: apropos of 30 cases in Aquitaine]J M Ragnaud, P Morlat, M Buisson, et al.
Pageof 18